Funding search · EIN 262343375 · Tulsa, OK

The Nancy Taylor Foundation

A private foundation (files IRS Form 990-PF). Most private foundations do not take unsolicited applications; the route in is usually a program officer.

13
grants reported
$1.4M
total given
2022–2024
filing years
$108,000
median grant

Based on grants this organization reported to the IRS for tax years 20222024. This is what they filed, not a complete record of their giving, and recent years may be incomplete because filings lag.

Full IRS filings ↗How this is builtReport an error

Funding pattern

What this funder pays for, at what size, and how to position adjacent work. Read from their filings, with every number checked against the record.

Sign in to analyze this funder’s giving pattern. Free in early access.

2 grants matching “idiopathic · $345,600

  • $129,600

    The Nemours Foundation · Wilmington, DE · 2024

    "examining the role of fibroblast-like synoviocytes in juvenile idiopathic arthritis" by anne marie brescia, m.d.

  • $216,000

    Nemours Foundationalfred I Dupont H · Wilmington, DE · 2022

    Prognostic synovial biomarkers in juvenile idiopathic arthritis by annemarie brescia, m.d.

Grant history

All 13 reported grants, largest first.

  • $216,000

    Nemours Foundationalfred I Dupont H · Wilmington, DE · 2022

    Prognostic synovial biomarkers in juvenile idiopathic arthritis by annemarie brescia, m.d.

  • $212,000

    University of Pittsburgh · Pittsburgh, PA · 2022

    Translational evaluation of the pathogenicity of dnt cells in rheumatic diseases of children and in a mouse model of early early-onset synovitis by abbe n. De vallejo, ph.d.

  • $129,600

    The Nemours Foundation · Wilmington, DE · 2024

    "examining the role of fibroblast-like synoviocytes in juvenile idiopathic arthritis" by anne marie brescia, m.d.

  • $108,000

    Children'S Hospital of Philadelphia · Philadelphia, PA · 2024

    Project to investigate potential mechanisms by which nrf2 represses il 12b with a potential genome-wide effect and the role of nrf2-nfil3 interactions in il 12b repression by nrf2 by edward m. Behrens, m.d.

  • $108,000

    Yale University · New Haven, CT · 2024

    "novel approaches to treating chronic diseases" by stephen waxman, m.d ph.d.

  • $108,000

    Yale University · New Haven, CT · 2023

    Targeted neurofeedback: a novel nonpharmological treatment for ocd by dr. Chris pittenger

  • $108,000

    Children'S Hospital of Philadelphia · Philadelphia, PA · 2022

    Mechanisms of mmf/ho-1 regulation of hyperinflammation by dr. Behren.

  • $108,000

    Yale University · New Haven, CT · 2022

    Targeted neurofeedback: a novel nonpharmological treatment for ocd by dr. Chris pittenger

  • $108,000

    Yale University · New Haven, CT · 2022

    Novel approaches to the study of pain and targeting of chronic pain by dr. Waxman.

  • $100,000

    University of Pittsburgh · Pittsburgh, PA · 2023

    Cellular phenotype contributing to immune dysregulation in localized scleroderma by kathryn torok, m.d.

  • $100,000

    University of Pittsburgh · Pittsburgh, PA · 2022

    Cellular phenotype contributing to immune dysregulation in localized scleroderma by kathryn torok, m.d.

  • $25,000

    National Cfids Foundation · Needham, MA · 2023

    To support research

  • $-930

    Yale University · New Haven, CT · 2024

    Return of unspent funds

Who else funds this kind of work

Same state

Similar grant size

Grants already paid are the record; PaperOrbit reads your paper and finds the funders whose record matches it — then explains why.

Search funders like this one

Source: IRS Form 990-PF, Part XV, as filed by the foundation. These are grants already paid — a record of what this funder backs, not an open call.